Mestag Therapeutics Company Profile, Contacts & Intelligence
Mestag Therapeutics Overview
Mestag focuses on fibroblast-immune interactions to develop innovative new treatments for inflammatory disease and cancer. Through our unique understanding of fibroblast immunology, we are advancing a pipeline of first-in-class antibody programs and targets for new treatments. Backed by committed leading global investors, world-class founders and a highly experienced leadership team, Mestag offers an exciting, diverse and balanced place to work, with competitive benefits, generous vacation time and the room to grow and develop your career.
- Headquarters
- London, City of, United Kingdom
- Website
- mestagtherapeutics.com
- Industry
- Biotechnology Research
- Founded
- 2020
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology)
Mestag Therapeutics Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
Mestag Therapeutics People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
Mestag Therapeutics Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to Mestag Therapeutics
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Autolus Therapeutics | Biotechnology | 736 | View company |
| Bicycle Therapeutics | Biotechnology Research | 344 | View company |
| Bit.Bio | Biotechnology Research | 164 | View company |
| Quell Therapeutics | Biotechnology Research | 151 | View company |
| AviadoBio | Biotechnology Research | 77 | View company |
| Amphista Therapeutics Limited | Biotechnology Research | 65 | View company |
| CHARM Therapeutics | Research Services | 58 | View company |
| Alchemab Therapeutics Ltd | Biotechnology Research | 54 | View company |
| Maxion Therapeutics | Biotechnology | 45 | View company |
| Laverock Therapeutics | Biotechnology Research | 39 | View company |